Weifa ASA Share Price

Stocks

WEIFA

NO0010308240

Pharmaceuticals

Latest news: Weifa ASA

17/10/17	Weifa ASA Announces Board Appointments	CI
05/10/17	Karo Pharma AB (OM:KARO) completed the acquisition of Weifa ASA (OB:WEIFA) from Holta Life Sciences AS, Watrium AS and others.	CI
25/09/17	An unknown buyer acquired 9.1% stake in Weifa ASA (OB:WEIFA) from MVN Event Driven Master Fund Limited fund managed by MVN Asset Management Limited and MVN Asset Management Limited.	CI
18/09/17	Weifa ASA(OB:WEIFA) dropped from S&P Global BMI Index	CI
23/08/17	Karo Pharma AB (OM:KARO) entered into a transaction agreement to make an offer to acquire Weifa ASA (OB:WEIFA) from Holta Life Sciences AS, Watrium AS and others for NOK 1.3 billion.	CI
13/07/17	Weifa ASA Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	CI
30/05/17	Weifa ASA Announces Dividend, Payable on June 8, 2017	CI
28/04/17	Weifa ASA Announces Audited Consolidated and Parent Earnings Results for the Year Ended December 31, 2016	CI
19/03/17	The mutual funds managed by Nordea Funds Oy acquired an additional 0.54% stake in Weifa ASA (OB: WEIFA).	CI
16/02/17	Weifa ASA Proposes Dividend for the Fourth Quarter of 2016, Payable on June 8, 2017	CI
16/02/17	Weifa ASA Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016	CI
12/01/17	Weifa Announces New License Agreement with AFT Pharmaceuticals for Nordic Rights to Groundbreaking Product Line Within Pain Management	CI
25/10/16	Weifa ASA Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016; Provides Earnings Guidance for 2016	CI

More news

Press Releases: Weifa ASA

17/10/17	Weifa : ASA - minutes of extraordinary general meeting	GL
11/10/17	Weifa : ASA announces change to its financial calendar	GL
06/10/17	Weifa : Karo Pharma AB completes voluntary offer for Weifa ASA	GL
05/10/17	Weifa : Final result of the voluntary offer for Weifa ASA	GL
03/10/17	Weifa : KARO PHARMA AB'S TAKEOVER OFFER FOR WEIFA ASA SUCCESSFUL	GL

More press releases

Quotes and Performance

1 day

+1.10%

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WEIFA ASA	+1.10%	-.--%	-	-	0
ELI LILLY AND COMPANY	+2.83%	+4.40%	+60.84%	+123.50%	1,165B
JOHNSON & JOHNSON	+3.81%	+5.66%	+38.70%	+74.91%	645B
ABBVIE INC.	+0.14%	+0.63%	+24.71%	+95.03%	504B
ROCHE HOLDING AG	+0.03%	+3.27%	+39.79%	+64.06%	380B
MERCK & CO., INC.	-1.76%	+1.41%	+68.06%	+43.41%	363B
NOVARTIS AG	+1.58%	+2.37%	+22.91%	+51.98%	297B
ASTRAZENECA PLC	+2.90%	+2.22%	+3.51%	+24.45%	269B
AMGEN INC.	+2.04%	+3.05%	+51.12%	+60.42%	237B
GILEAD SCIENCES, INC.	+2.36%	-0.11%	+29.42%	+102.04%	195B
Average	+1.68%	+2.19%	+37.67%	+71.09%	450.61B
Weighted average by Cap.	+1.98%	+2.60%	+42.84%	+82.95%